Vanda Pharmaceuticals News

Vanda Pharmaceuticals | 8-A12B/A: Registration of a class of securities on a national securities exchange (Amendment)

Aug 8 07:49 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 29 17:25 ET

Vanda Pharmaceuticals | 8-A12B/A: Registration of a class of securities on a national securities exchange (Amendment)

May 3 16:30 ET

Vanda Pharmaceuticals | 8-A12B: Registration of a class of securities on a national securities exchange

Apr 17 17:30 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 21:16 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 21:16 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 21:11 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 21:11 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 21:11 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 21, 2023 17:07 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 10, 2023 17:44 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 28, 2023 16:30 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 15, 2023 18:02 ET

Vanda Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 13, 2023 20:29 ET

Vanda Pharmaceuticals | EFFECT: Others

May 8, 2023 00:15 ET

Vanda Pharmaceuticals | 424B5: Prospectus

Mar 16, 2018 16:33 ET

Vanda Pharmaceuticals | 424B5: Prospectus

Mar 14, 2018 16:13 ET